Last reviewed · How we verify
Femoston
At a glance
| Generic name | Femoston |
|---|---|
| Also known as | Complex Packing Estradiol Tablets/Estradiol and Dydrogesterone Tablets, Hormones |
| Sponsor | Affiliated Hospital of Nantong University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion (PHASE1)
- QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology (NA)
- Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons (NA)
- Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer (NA)
- Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction (PHASE4)
- Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women (PHASE4)
- Thin Endometrium Undergoing Frozen-thawed Embryo Transfer (NA)
- The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Femoston CI brief — competitive landscape report
- Femoston updates RSS · CI watch RSS
- Affiliated Hospital of Nantong University portfolio CI